Sagimet Biosciences Inc.

Contributing Author

Recent Articles by Sagimet Biosciences Inc.

May-22	Sagimet Biosciences to Host Virtual KOL Event, "Evaluating the Synergistic Potential of a Combination of Denifanstat and Resmetirom for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)" on May 29, 2025 SGMT +5.90% GlobeNewswire
May-08	Sagimet Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates SGMT GlobeNewswire